Antibiotic Resistance: Public Health Problem

Antibiotic resistance is a major public health problem in Europe and worldwide. Indeed, it increases morbidity and mortality due to communicable diseases, resulting in a deterioration in the quality of life and increased costs in health and medical care.

Antibiotics are essential to fight against infectious diseases. It is therefore imperative to preserve the effectiveness of pharmaceuticals that are still effective.

Antibiotic resistance and the various factors that have enabled it to grow requires a multidisciplinary approach and multisectoral. In this area, national initiatives are not sufficient to reduce risks, and effectively prevent the micro-organisms becoming resistant to antibiotics used in human and veterinary medicine and animal feed, or to preserve the effectiveness of antibiotics in the treatment of infectious diseases. A common strategy and coordinated action is therefore required at Community and international.

Given the global dimension of this problem, it is necessary that Member States and the Commission are actively sharing the aims of this resolution by international organizations, in particular by the World Health Organization (WHO ), the UN Food and Agriculture Organization (FAO) and the Office International des Epizooties (OIE).

In the Commission's overall strategy should be based on a risk assessment and include a coordinated control and preventive action (eg, monitoring of antibiotic resistance and its consequences in humans and animals and in food, fight against infections in health care and livestock production, development of new therapeutic and preventive medicines etc..) and research (including the effects of preventive measures, the development of new antibiotics and of alternatives, improved use of antibiotics, mechanisms of the spread and development of antibiotic resistance or even the best management practices to improve the health of animals).

As part of this strategy, Member States are invited to:

    develop multidisciplinary and multisectoral policies to help stop the development of antibiotic resistance;
    cooperate to ensure effective control and comparable to the provision and use of antibiotics and an effective comparable surveillance of antibiotic resistance;
    defend the principle that antibiotics whose use is authorized in human and veterinary medicine, drugs are "prescription only" and to be vigilant about the implementation of this principle;
    promote adherence to the principles of the fight against nosocomial infections as in non-hospital setting and in animal production;
    optimal prescribing and use of antibiotics (through training of health professionals, the publication of guidelines, etc..) and to prevent unnecessary or inappropriate uses in human and veterinary medicine;
    promote activities to increase awareness of health professionals, farmers and the public about the problem of antibiotic resistance;
    promote livestock production systems focusing on health, reducing the need for antibiotics;
    promote research in this area;
    cooperate closely with the Commission, including in the above areas.

The Commission is invited to:

    include, as a priority, monitoring of antibiotic resistance in human medicine and in the fight against zoonoses and promote complementarity of this surveillance through the Community network for epidemiological surveillance and the fight against communicable diseases;

    ensure, on the basis of comparable data provided by Member States, that a report be made on the provision and use of antibiotics, including human and veterinary medicine, as well as in animal feed, the horticulture and other agricultural products and foodstuffs, and to draw conclusions;

    support the exchange of experiences and information on the rational use of antibiotics by appropriate community action;

    promote, through the implementation of the Fifth Framework Programme, research on, for example on the evolution of antibiotic resistance in bacterial populations and understanding of the transmissibility of resistant bacteria in humans in animals and the environment;

    consider the advisability of developing a proposal for a recommendation pursuant to the Treaty;

    consider whether it is necessary to amend the existing Community legislation in the field of human and veterinary medicine;

    pay particular attention to the problem of antibiotic resistance in specific health actions related to the candidate countries, particularly in the Phare 2000;

The Commission shall promote cooperation in close coordination with Member States and relevant international organizations.

Come to our page if you want to learn more about what are the types of antibiotics. Also read the description of the modern antibiotics - Amoxil (Amoxicillin) and Tetracycline - it uses, side effects, dosage and mechanism of action.

No comments:

Post a Comment